So Lets discuss the pros and cons on this company and get a gauge of what we are looking at over the coming months:
1. Penn requesting info on the licenses and information on why Harvest thinks they can have more than the state allows. Will the latest acquisition be allowed to close, Cannapharmacy
2. Share lock up expires may 14th or 15th, I believe after market close on the 14th. 220 million shares
3. No legislation passing
4. Hemp cross pollenization with some of harvest cannabis fields
5. Harvest not getting into CBD oil
6. Curaleaf and Acreage growing faster than them potentially as they have more ammo in terms of capital now.
Pro's
1. Management is of the highest quality of all the MSO's, right up there at least with the best.
2. Management is incentivized by the stock price going up as they all have major skin in the game as some employees have decided on share compensation instead of salary.
3. Verano deal looks like they paid a bargain price for all they are getting
4. 500 million raise by one investor at 7%
5. Could be grandfathered in before some of the states attempt to change the laws like Penn so they don't have companies getting a ton of licenses where they aren't intended to.
6. 2019 and 2020 revenue and margin guidance- the only company to give both and it is only taking into account whats already recreational and medically legal. Upside in more states coming on board
7. Legislation passing- safe banking, states act, federal prohibition?
8. More deals in the pipeline
thoughts?
